您的位置: 百康网 > 期刊 > 皮肤病学与性病学 > 《传染病的形成》 > 2006年 > 2006年8月第8期 > 正文
Detecting Clostridium botulinum
 本页关键词:Clostridium
2007-6-14 20:23:41

    Medical University Innsbruck, Innsbruck, Austria

    C. botulinum comprises a heterogenous group of subspecies that produce botulinum neurotoxin (BoNT); identification and characterization usually rely on animal testing that focuses on antigenetically distinct toxins (2). Although strains of C. botulinum that do not produce toxins are sometimes isolated from wound infections not related to botulism, some strains of C. butyricum and C. baratii are also able to produce BoNTs.

    The mouse bioassay is currently the accepted method for detecting BoNT. In this assay, mice that receive an intraperitoneal injection containing a sample with more than a minimum lethal dose show symptoms of botulinum intoxication and die. ELISAs, which recognize protein antigenic sites, are still less sensitive than the mouse bioassay (3).

    Because the mouse bioassay requires euthanizing many animals, and results are not available for several hours, new diagnostic methods are needed. For C. botulinum, an organism widely dispersed in the environment, DNA-based methods may not provide the ultimate solution. Rapid methods to detect and differentiate active BoNTs, such as the rapid, mass spectrometry-based, functional method, are promising candidates to substitute for animal testing in the near future (4).

    References

    Song L, Ahn S, Walt DR. Detecting biological warfare agents. Emerg Infect Dis. 2005;11:1629–32.

    Grif K, Dierich MP, Much P, Hofer E, Allerberger F. Identifying and subtyping species of dangerous pathogens by automated ribotyping. Diagn Microbiol Infect Dis. 2003;47:313–20.

    Ferreira JL, Eliasberg SJ, Edmonds P, Harrison MA. Comparison of the mouse bioassay and enzyme-linked immunosorbent assay procedures for the detection of type A botulinal toxin in food. J Food Prot. 2004;67:203–6.

    Barr JR, Moura H, Boyer AE, Woolfitt AR, Kalb SR, Pavlopoulos A, et al. Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis. 2005;11:1578–83.



查询更多Clostridium相关信息在本站>>

  

《传染病的形成》2006年8月第12卷第8期 

评论】【打印】【 】【关闭
相关文章
Clostridium difficile PCR Ribotypes in Calves, Canada
Humans as Reservoir for Enterotoxin Gene–carrying Clostridium perfringens Type A
ICD-9 Codes and Surveillance for Clostridium difficile–associated Disease
Epidemic Clostridium difficile Strain in Hospital Visitation Dog
Epidemic Clostridium difficile Strain in Hospital Visitation Dog
Clostridium difficile Ribotype 027, Toxinotype III, the Netherlands
Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–20031
Angiotensin II Subtype 1 Receptor Blockade Inhibits Clostridium difficile Toxin AInduced Intestinal Secretion in a Rabbit Model
Activation of Platelet gpIIbIIIa by Phospholipase C from Clostridium perfringens Involves Store-Operated Calcium Entry
Rickettsia felis in Xenopsylla cheopis, Java, Indonesia